You have no items in your shopping cart.

Subtotal: $0.00

Toll Free:(877) 452-9925

puromycin CRISPR Cas9- genome editing

More Views

Puromycin, dihydrochloride

CAS: 58-58-2 Formula: C22H29N7O5 2HCl MW: 544.4 Purity: >98% by HPLC
Hazardous

3

0

1

PRODUCT # SIZE LIST PRICE QUANTITY BUY NOW BULK INQUIRIES
P-1033 25 mg
$41.36
Bulk Inquiry
100 mg
$108.57
Bulk Inquiry
500 mg
$367.07
Bulk Inquiry
1 g
$450.31
Bulk Inquiry

BULK INQUIRY FORM

* Required Fields

*
*
*
*
*
*Bulk OEM Multiple Catalog Custom Other
Prod# CAS# *PRODUCT NAME Grade *Size *Qty Time Frame

Custom magento captcha module from Outsource Online  

Puromycin Hydrochloride is the hydrochloride salt form of puromycin, an aminoglycoside antibiotic isolated from the bacterium Streptomyces alboniger. Acting as an analog of the 3' terminal end of aminoacyl-tRNA, puromycin incorporates itself into a growing polypeptide chain and causes its premature termination, thereby inhibiting protein synthesis. This agent has antimicrobial, antitrypanosomal, and antineoplastic properties. Puromycin's main application is in cell biology as a selective antibiotic agent in cell culture systems for selecting mammalian cell lines, which have been transformed by vectors that express puromycin-N-acetyl-transferase (PAC). Puromycin’s longstanding application as a gene selection antibiotic has a powerful new role in Genome editing utilizing the CRISPR/Cas9 system.

 

 

Additional Information

Synonyms Stylomycin dihydrochloride, CL 13900 dihydrochloride, CL16536, NSC 3055, P638 dihydrochloride.
Product # P-1033
CAS # 58-58-2
Chemical Name (S) 3'-[[2-Amino-3-(4-methoxyphenyl)-1-oxopropyl]amino]-3'-deoxy-N,N-dimethyladenosine,3'-(a-Amino-p-methoxy-hydocinnamamido)-3'-dexoy-N,N-dimethyladenosine.2HCl
Formula C22H29N7O5 2HCl
MW 544.4
Purity >98% by HPLC
Solubility Soluble in water (50 mg/ml), ethanol (~1 mg/ml), DMSO (~13 mg/ml), DMF (~14 mg/ml), and PBS, pH 72 (~10 mg/ml)
Melting Point 175-177 °C
Boiling Point 752.16 °C
Storage Temp -20°C
Therapeutic Area Infectious Diseases
Use An aminonuclease antibiotic used for selection and maintenance of cell lines expressing a transfected pac gene

Additional Information

Merck Index 14: 7943
MDL Number MFCD00866328
ChemACX X1001900-0
InChI InChI=1S/C22H29N7O5/c1-28(2)19-17-20(25-10-24-19)29(11-26-17)22-18(31)16(15(9-30)34-22)27-21(32)14(23)8-12-4-6-13(33-3)7-5-12/h4-7,10-11,14-16,18,22,30-31H,8-9,23H2,1-3H3,(H,27,32)/t14-,15+,16+,18+,22+/m0/s1
SMILES CN(C)C1=NC=NC2=C1N=CN2C3C(C(C(O3)CO)NC(=O)C(CC4=CC=C(C=C4)OC)N)O

Additional Information

RTECS AU7350000
UN #'S UN 2811
PACKING GROUP I

Additional Information

msds 1 P-1033, SDS.pdf
Certificate of Analysis 1 P-1033, H1192A.pdf
Certificate of Analysis 2 P-1033, H1192.pdf
Certificate of Analysis 3 P-1033, H1142A.pdf

Additional Information

Citations CELL BIOLOGY:\n CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53\n Dingding Shi, Marius S. Pop, Roman Kulikov, Ian M. Love, Andrew L. Kung, and Steven R. Grossman\n PNAS, Sep 2009; 106: 16275 - 16280.
NEOPLASIA:\n High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia\n Marco Herling, Kaushali A. Patel, Michael A. Teitell, Marina Konopleva, Farhad Ravandi, Ryuji Kobayashi, and Dan Jones\n Blood, Jan 2008; 111: 328 - 337.
Ligand-Independent Regulation of Transforming Growth Factor ß1 Expression and Cell Cycle Progression by the Aryl Hydrocarbon Receptor \n Xiaoqing Chang, Yunxia Fan, Saikumar Karyala, Sandy Schwemberger, Craig R. Tomlinson, Maureen A. Sartor, and Alvaro Puga\n Mol. Cell. Biol., Sep 2007; 27: 6127 - 6139.
The mTORC1 signaling repressors REDD1/2 are rapidly induced and activation of p70S6K1 by leucine is defective in skeletal muscle of an immobilized rat hindlimb\n Andrew R. Kelleher, Scot R. Kimball, Michael D. Dennis, Rudolf J. Schilder, and Leonard S. Jefferson\n Am J Physiol Endocrinol Metab, Jan 2013; 304: E229 - E236.
CELL, TUMOR, AND STEM CELL BIOLOGY:\n Inhibition of Gastric Cancer Invasion and Metastasis by PLA2G2A, a Novel β-Catenin/TCF Target Gene\n Kumaresan Ganesan, Tatiana Ivanova, Yonghui Wu, Vikneswari Rajasegaran, Jeanie Wu, Ming Hui Lee, Kun Yu, Sun Young Rha, Hyun Cheol Chung, Bauke Ylstra, Gerrit Meijer, Kon Oi Lian, Heike Grabsch, and Patrick Tan\n Cancer Res., Jun 2008; 68: 4277 - 4286.
The Aryl Hydrocarbon Receptor Binds to E2F1 and Inhibits E2F1-induced Apoptosis\n Jennifer L. Marlowe, Yunxia Fan, Xiaoqing Chang, Li Peng, Erik S. Knudsen, Ying Xia, and Alvaro Puga\n Mol. Biol. Cell, Aug 2008; 19: 3263 - 3271.
STRUCTURE AND ASSEMBLY:\n Fluorescent Tagging and Cellular Distribution of the Kaposi's Sarcoma-Associated Herpesvirus ORF45 Tegument Protein\n Shir Bergson, Inna Kalt, Inbal Itzhak, Kevin F. Brulois, Jae U. Jung, and Ronit Sarid\n J. Virol., Nov 2014; 88: 12839 - 12852.
PATHOGENESIS AND IMMUNITY:\n Hepatitis C Virus Entry Is Impaired by Claudin-1 Downregulation in Diacylglycerol Acyltransferase-1-Deficient Cells\n Pil Soo Sung, Asako Murayama, Wonseok Kang, Myung-Sun Kim, Seung Kew Yoon, Masayoshi Fukasawa, Masuo Kondoh, Jin-Soo Kim, Hyongbum Kim, Takanobu Kato, and Eui-Cheol Shin\n J. Virol., Aug 2014; 88: 9233 - 9244.
ORIGINAL MANUSCRIPT:\n Exosome-derived miRNAs and ovarian carcinoma progression\n Olga Vaksman, Claes Tropé, Ben Davidson, and Reuven Reich\n Carcinogenesis, Sep 2014; 35: 2113 - 2120.
ORIGINAL MANUSCRIPT:\n Exosome-derived miRNAs and ovarian carcinoma progression\n Olga Vaksman, Claes Tropé, Ben Davidson, and Reuven Reich\n Carcinogenesis, Sep 2014; 35: 2113 - 2120.
Reference The Aryl Hydrocarbon Receptor Binds to E2F1\nand Inhibits E2F1-induced Apoptosis
High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia
AG490 and PF431396 Sensitive Tyrosine Kinase Control the Population Heterogeneity of Basal STAT1 Activity in Ube1l Deficient Cells - Hesung Now, Joo-Yeon Yoo

Additional Information

Puromycin, dihydrochloride

USD

$0.00

0